Author

Adc Therapeutics

View on Semantic Scholar

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review

This review seeks to examine the safety, efficacy, and feasibility of anti-PD-1 therapy in classical Hodgkin lymphoma.

J. Day, S. Ansell, Takeda Regeneron AstraZeneca Pfizer Affimed StepPharma Bristol Myers Squibb et al. · 0 citations